We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Canada Issues Renewed Warning Over Chantix

Law360 (January 7, 2009, 12:00 AM EST) -- Canadian health officials are reiterating their concerns over Pfizer Inc.'s smoking-cessation drug Chantix as they mull further strengthening the drug's labeling to address the risk of serious adverse psychiatric effects that...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.